Imane Chaib
Badalona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Kisspeptins and norepinephrine regulate different G-protein-coupled receptor signaling pathways.
Journal: Translational lung cancer research
Published: June 30, 2022
Dihydroartemisinin overcomes the resistance to osimertinib in EGFR-mutant non-small-cell lung cancer.
Journal: Pharmacological research
Published: March 04, 2021
SRC and PIM1 as potential co-targets to overcome resistance in MET deregulated non-small cell lung cancer.
Journal: Translational lung cancer research
Published: November 19, 2020
BRCA1 Expression and Outcome in Patients With EGFR-Mutant NSCLC Treated With Gefitinib Alone or in Combination With Olaparib.
Journal: JTO clinical and research reports
Published: June 18, 2020
Src-Homology 2 Domain-Containing Phosphatase 2 in Resected EGFR Mutation-Positive Lung Adenocarcinoma.
Journal: JTO clinical and research reports
Published: May 14, 2020
Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies.
Journal: Cancers
Published: April 17, 2020
Targeting MET amplification in EGFR-mutant non-small-cell lung cancer.
Journal: The Lancet. Respiratory medicine
Published: March 29, 2020
Osimertinib and dihydroartemisinin: a novel drug combination targeting head and neck squamous cell carcinoma.
Journal: Annals of translational medicine
Published: January 14, 2020
Last Updated: 09/26/2026